Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX
LAFAYETTE, La., Dec. 07, 2023 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval from the Toronto Stock Exchange (“TSX”) for the voluntary delisting of its common shares (each a “Common Share”) from the TSX. The delisting from TSX will not affect the Company’s listing on the NASDAQ Capital Market (“NASDAQ”).
Related news for (VMD)
- Viemed Healthcare Announces Share Repurchase Program
- Revolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients with RAS Mutant Non-Small Cell Lung Cancer
- Viemed Healthcare Announces First Quarter 2025 Financial Results
- Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
- Viemed Healthcare Announces Record 2024 Financial Results